These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 28815294
1. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of glioma cells by inactivating Wnt/β-catenin signaling. Tao Q, Wu C, Xu R, Niu L, Qin J, Liu N, Zhang P, Wang C. Cell Tissue Res; 2017 Dec; 370(3):379-390. PubMed ID: 28815294 [Abstract] [Full Text] [Related]
2. Inhibition of oleandrin on the proliferation show and invasion of osteosarcoma cells in vitro by suppressing Wnt/β-catenin signaling pathway. Ma Y, Zhu B, Liu X, Yu H, Yong L, Liu X, Shao J, Liu Z. J Exp Clin Cancer Res; 2015 Oct 06; 34():115. PubMed ID: 26444270 [Abstract] [Full Text] [Related]
3. Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth. Lai KC, Hsu SC, Yang JS, Yu CC, Lein JC, Chung JG. J Cell Mol Med; 2015 Feb 06; 19(2):474-84. PubMed ID: 25403643 [Abstract] [Full Text] [Related]
4. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells. Zhang Q, Li XT, Chen Y, Chen JQ, Zhu JY, Meng Y, Wang XQ, Li Y, Geng SS, Xie CF, Wu JS, Zhong CY, Han HY. Cancer Chemother Pharmacol; 2018 Jun 06; 81(6):969-977. PubMed ID: 29594332 [Abstract] [Full Text] [Related]
5. Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Li Y, Zhang J, Zhang L, Si M, Yin H, Li J. Carcinogenesis; 2013 Jul 06; 34(7):1601-10. PubMed ID: 23430952 [Abstract] [Full Text] [Related]
6. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway. Xia S, Ji R, Zhan W. BMC Neurol; 2017 Feb 10; 17(1):30. PubMed ID: 28187755 [Abstract] [Full Text] [Related]
7. Endostar, a modified recombinant human endostatin, suppresses angiogenesis through inhibition of Wnt/β-catenin signaling pathway. Xu X, Mao W, Chen Q, Zhuang Q, Wang L, Dai J, Wang H, Huang Z. PLoS One; 2014 Feb 10; 9(9):e107463. PubMed ID: 25232946 [Abstract] [Full Text] [Related]
8. Diallyl sulfide, diallyl disulfide, and diallyl trisulfide inhibit migration and invasion in human colon cancer colo 205 cells through the inhibition of matrix metalloproteinase-2, -7, and -9 expressions. Lai KC, Hsu SC, Kuo CL, Yang JS, Ma CY, Lu HF, Tang NY, Hsia TC, Ho HC, Chung JG. Environ Toxicol; 2013 Sep 10; 28(9):479-88. PubMed ID: 21695758 [Abstract] [Full Text] [Related]
9. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway. He P, Wang Z, Sheng B, Xu Y, Feng S, Huang Y, Gong F, Tang L, Xie L. Histol Histopathol; 2020 Dec 10; 35(12):1511-1520. PubMed ID: 33372687 [Abstract] [Full Text] [Related]
10. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma. Xie D, Xie J, Wan Y, Ma L, Qi X, Wang K, Yang S. Oncol Rep; 2016 Apr 10; 35(4):2191-7. PubMed ID: 26781164 [Abstract] [Full Text] [Related]
11. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells. Wang Z, Li B, Zhou L, Yu S, Su Z, Song J, Sun Q, Sha O, Wang X, Jiang W, Willert K, Wei L, Carson DA, Lu D. Proc Natl Acad Sci U S A; 2016 Nov 15; 113(46):13150-13155. PubMed ID: 27799526 [Abstract] [Full Text] [Related]
12. Diallyl Trisulfide inhibits breast cancer stem cells via suppression of Wnt/β-catenin pathway. Li X, Meng Y, Xie C, Zhu J, Wang X, Li Y, Geng S, Wu J, Zhong C, Li M. J Cell Biochem; 2018 May 15; 119(5):4134-4141. PubMed ID: 29243835 [Abstract] [Full Text] [Related]
13. MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7. Yue X, Cao D, Lan F, Pan Q, Xia T, Yu H. Neuro Oncol; 2016 Sep 15; 18(9):1288-96. PubMed ID: 27006177 [Abstract] [Full Text] [Related]
14. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Wiese M, Walther N, Diederichs C, Schill F, Monecke S, Salinas G, Sturm D, Pfister SM, Dressel R, Johnsen SA, Kramm CM. Oncotarget; 2017 Apr 18; 8(16):27300-27313. PubMed ID: 28460484 [Abstract] [Full Text] [Related]
15. Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R, Singh SV. Clin Cancer Res; 2006 Nov 15; 12(22):6836-43. PubMed ID: 17121905 [Abstract] [Full Text] [Related]
16. Wnt/β-catenin modulates chronic tobacco smoke exposure-induced acquisition of pulmonary cancer stem cell properties and diallyl trisulfide intervention. Wang J, Chen J, Jiang Y, Shi Y, Zhu J, Xie C, Geng S, Wu J, Zhang Q, Wang X, Meng Y, Li Y, Chen Y, Cao W, Wang X, Zhong C, Li X. Toxicol Lett; 2018 Jul 15; 291():70-76. PubMed ID: 29626521 [Abstract] [Full Text] [Related]
17. SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways. Yang J, Yang Q, Yu J, Li X, Yu S, Zhang X. Oncol Rep; 2016 Jun 15; 35(6):3566-76. PubMed ID: 27108836 [Abstract] [Full Text] [Related]
18. The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma. Ni H, Ji D, Li J, Zhao Z, Zuo J. Int J Biol Macromol; 2021 Apr 15; 176():145-156. PubMed ID: 33571591 [Abstract] [Full Text] [Related]
19. SOX15 exerts antitumor function in glioma by inhibiting cell proliferation and invasion via downregulation of Wnt/β-catenin signaling. Zhang D, Guo S, Wang H, Hu Y. Life Sci; 2020 Aug 15; 255():117792. PubMed ID: 32416168 [Abstract] [Full Text] [Related]
20. Ganoderma lucidum Exerts an Anticancer Effect on Human Osteosarcoma Cells via Suppressing the Wnt/β-Catenin Signaling Pathway. Zhang QH, Hu QX, Xie D, Chang B, Miao HG, Wang YG, Liu DZ, Li XD. Integr Cancer Ther; 2019 Aug 15; 18():1534735419890917. PubMed ID: 31855073 [Abstract] [Full Text] [Related] Page: [Next] [New Search]